Pharmaceutial & Healthcare

The global Drugs for Herpes Labialis (Oral Herpes) market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Drugs for Herpes Labialis (Oral Herpes) from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Drugs for Herpes Labialis (Oral Herpes) market. Request a Sample Copy of This Report: https://www.radiantinsights.com/research/2013-2028-report-on-global-drugs-for-herpes-labialis-oral-herpes-market/request-sample Leading players of Drugs for Herpes Labialis (Oral Herpes) including: GSK Novartis Teva Mylan Cadila Apotex Daewoong Pharmaceutical Livzon Luoxin Med shine Bayer (Campho Phenique) Blistex Kel

The global Bacterial Vaginosis Drug market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Bacterial Vaginosis Drug from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Bacterial Vaginosis Drug market. Request a Sample Copy of This Report: https://www.radiantinsights.com/research/2013-2028-report-on-global-bacterial-vaginosis-drug-market/request-sample Leading players of Bacterial Vaginosis Drug including: Bayer Pfizer Sanofi Piramal Abbott Galderma Mission Alkem Xiuzheng Teva Perrigo West-Ward HPGC Yunnan Baiyao Starpharma Novel Edenvridge Market split by Type, can be divided into: Rx O

The global myasthenia gravis treatment market size is expected to reach USD 2.06 billion by 2026 at a CAGR of 7.5% through the forecast period, according to a new report by Radiant Insights, Inc. Increasing awareness of rare diseases, emergence of biologics, and growing adoption of immunotherapies & immunosuppressants are driving the myasthenia gravis (MG) treatment market. Myasthenia gravis (MG) is a rare autoimmune disorder caused by an antibody mediated neuromuscular transmission obstruction that results in skeletal muscle weakness. Some of the disorders associated with the disease include drooping eyelids, double vision, trouble walking, and trouble talking. Patients with MG present with painless muscle weakness that worsens with repeated use and improves with rest. Request a Sample Copy of This Report: https://www.radiantinsights.com/research/myasthenia-gravis-treatment-market/request-sample According to the National Organization for Rare Disorders (NORD), in the U.S. a

The global workplace stress management market size is expected to reach USD 13.38 billion by 2026, expanding at a CAGR of 8.4% during the forecast period, according to a new report by Radiant Insights, Inc Rising promotion of employee health and wellbeing is augmenting the market growth. Many enterprises in different industry verticals implement employee health programs boosting market demand for workplace stress management services. According to the American Psychological Association, 58% of the country's population claims workplace as a significant source of stress. Occupational stress resulted in a loss of USD 300 billion due to employee illness, absenteeism, and productivity. In 2018, a survey conducted by Cigna TTK Health Insurance observed that around 89% of the Indian population suffer from stress as compared to the global average of 86%. Work and finances are the major cause of stress. However, over half of the respondents claimed to receive support and involvement in

The global Isoquinoline market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Isoquinoline from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Isoquinoline market. Request a Sample Copy of This Report: https://www.radiantinsights.com/research/2013-2028-report-on-global-isoquinoline-market/request-sample Leading players of Isoquinoline including: AIR WATER Huanghua Xinnuo Lixing Anshan Beida Shanxi Tianyu Shanghai Xinming Handan Huida Chemical Yalu Bio-chemical Market split by Type, can be divided into: 95% Content 96% Content 97% Content 98% Content Market split by Application, can be div

The global enzyme replacement therapy market size is expected to reach USD 12.13 billion by 2026, expanding at a CAGR of 7.7% during the forecast period, according to a new report by Radiant Insights, Inc As per the Genetic and Rare Diseases Information Center or GARD, a rare disease is defined as a condition that affects lesser than 200,000 individuals. These disorders are also called orphan diseases due to the lack of support exhibited by pharmaceutical companies previously. Since the passing of the Orphan Drug Act of 1983 in the U.S., several large pharmaceutical and biopharmaceutical companies have invested heavily in the development of orphan drugs. Thus, rising awareness, increasing R&D investment, growth in the number of lysosomal storage and genetic disorders, and easy drug approval process are factors propelling the market growth during the forecast period. According to data from the National Institutes of Health, it is estimated that over 25 million Americans suffer fr

The global healthcare interoperability solutions market size is expected to reach USD 4.7 billion by 2026, according to a new report by Radiant Insights, Inc., exhibiting a CAGR of 13.0% during the forecast period. Rising focus on patient-centric care, increasing need to curb high healthcare cost, and growing government initiatives to enhance patient safety & care are some major factors driving market growth. Rising healthcare IT penetration, especially in developing economies, is further expected to create significant growth opportunities for market players. However, rising complexity due to lack of reliable data & trained professionals and increasing data privacy & safety concerns are some key factors expected to impede growth. Healthcare organizations are adopting Electronic Health Record (EHR) systems that support integration between different technologies/systems, increasing the need for interoperability solutions across all healthcare settings. Interoperability sol

The global cancer registry software market exhibiting a CAGR of 10.5%. Growing incidence of cancer is expected to aid growth over the forecast period. Currently, cancer is the second leading cause of death globally, and according to WHO, around 70% of the deaths occur in low- and middle-income countries. Moreover, rising adoption of Electronic Health Records (EHRs) in developed countries and increasing need for cancer registries for post-marketing surveillance are among the factors further anticipated to boost the demand for cancer registry software in the coming years. Market players are constantly involved in software updation in an attempt to minimize security risks and provide efficient software, thereby increasing market visibility and adoption. For instance, in April 2018, Elekta invested in PalabraApps LLC to improve its MOSAIQ Oncology Information System software. Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/cancer-registry-software-marke

Kidney Cancer Drugs Market Global Report 2020 from Radiant Insights,Inc provides strategists, marketers and senior management with the critical information they need to assess the global kidney cancer drugs market. Reasons to Purchase • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies. • Create regional and country strategies on the basis of local data and analysis. • Identify growth segments for investment. • Outperform competitors using forecast data and the drivers and trends shaping the market. • Understand customers based on the latest market research findings. • Benchmark performance against key competitors. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high quality data and analysis • Report will be updated with the latest data and delivered to you within 3-5 working days of order. Reque

Ovarian Cancer Drugs Market Global Report 2020 from Radiant Insights, Inc provides strategists, marketers and senior management with the critical information they need to assess the global ovarian cancer drugs market. Reasons to Purchase • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies. • Create regional and country strategies on the basis of local data and analysis. • Identify growth segments for investment. • Outperform competitors using forecast data and the drivers and trends shaping the market. • Understand customers based on the latest market research findings. • Benchmark performance against key competitors. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high quality data and analysis • Report will be updated with the latest data and delivered to you within 3-5 working days of order. Req

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Healthcare Crm And Contact Centre Systems Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). In this report, the global Healthcare Crm And Contact Centre Systems market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2023, growing at a CAGR of XX% during the period 2019 to 2023. Request a Sample Copy of This Report: https://www.radiantinsights.com/research/global-healthcare-crm-and-contact-centre-systems-market-research-report-2019-2023/request-sample The report firstly introduced the Healthcare Crm And Contact Centre Syst

The global hunter syndrome treatment market size is expected to reach a value of USD 1.52 billion by 2026, expanding at a CAGR of 7.1%, according to a new report by  Radiant Insights, Inc High unmet needs, robust pipeline, increasing awareness about this rare disease and growing R&D activities for the development of novel therapies are expected to drive market growth over the forecast period. Hunter syndrome, also referred as mucopolysaccharidosis type II (MPS II), is a rare genetic disorder caused by the missing or malfunctioning iduronate-2-sulfatase enzyme. According to the data published by the National Institute of Neurological Disorders and Stroke, MPS II syndrome occurs in around 1 in every 100,000 to 150,000 male births. Presently, there are no approved curative therapies for the treatment of Hunter syndrome. The available treatment options such as enzyme replacement therapy (ERT) and hematopoietic stem cell transplant (HSCT) are focused on providing symptomatic relief

Gastric Cancer Drugs Market Global Report 2020 from Radiant Insights, Inc provides strategists, marketers and senior management with the critical information they need to assess the global gastric cancer drugs market. Reasons to Purchase • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies. • Create regional and country strategies on the basis of local data and analysis. • Identify growth segments for investment. • Outperform competitors using forecast data and the drivers and trends shaping the market. • Understand customers based on the latest market research findings. • Benchmark performance against key competitors. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high quality data and analysis • Report will be updated with the latest data and delivered to you within 3-5 working days of order. Re

The global irritable bowel syndrome treatment market size is expected to reach USD 3.3 billion by 2026, according to a new report by Radiant Insights, Inc exhibiting a 10.1% CAGR during the forecast period. Rising prevalence of target disease and increasing label extension of existing drugs are likely to accelerate market growth. In addition, growing uptake of drugs and launch of novel products are anticipated to drive the irritable bowel syndrome (IBS) treatment market. IBS is one of the most common gastrointestinal disorders, with the worldwide prevalence rate usually ranging between 10-15%. Most of the patients with IBS are under 50 years of age but many older adults suffer as well. The effect of the condition can vary from mild inconvenience to serious debilitation. It can control many facets of a patient's professional, emotional, and social life. Patients with moderate to severe conditions usually struggle with symptoms that frequently impair their emotional, physical, edu

The global Infertility Drugs market was valued at $XX million in 2018, and Radiant Insights,Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Infertility Drugs from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Infertility Drugs market. Request a Sample Copy of This Report: https://www.radiantinsights.com/research/2013-2028-report-on-global-infertility-drugs-market/request-sample Leading players of Infertility Drugs including: • Merck • Ferring • MSD • LIVZON • Abbott • Bayer Zydus Pharma Market split by Type, can be divided into: • Gonadotropins • Anti-Estrogens Market split by Application, can be divided into: • Male • Female Market split by Sales

The global Drugs for Schistosomiasis market was valued at $XX million in 2017, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028. This report provides detailed historical analysis of global market for Drugs for Schistosomiasis from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Drugs for Schistosomiasis market. Request a Sample Copy of This Report: https://www.radiantinsights.com/research/2013-2028-report-on-global-drugs-for-schistosomiasis-market/request-sample Leading players of Drugs for Schistosomiasis including: Shin Poong Merck Bayer EIPICO Chandra Bhagat Pharma Taj Pharmaceuticals Market split by Type, can be divided into: Praziquantel Oxamniquine Other Market split by Application, can be di

The global Disinfectant Gels market was valued at $XX million in 2018, and Radiant Insights,Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Disinfectant Gels from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Disinfectant Gels market. Request a Sample Copy of This Report: https://www.radiantinsights.com/research/2013-2028-report-on-global-disinfectant-gels-market/request-sample Leading players of Disinfectant Gels including: 3M Saraya PURELL DOW BODE Chemie Reckitt Benckiser Plum Shandong Weigao Group Beijing Xidebao Market split by Type, can be divided into: Hand Disinfectants Skin and Mucous Membrane Disinfectants Instrument Disinfectants Othe